Dr. Saadvik Raghuram y retweetledi
Dr. Saadvik Raghuram y
3.7K posts

Dr. Saadvik Raghuram y
@saadvikdr
Head of department Medical Oncology | Arete institute of oncology | Arete Hospitals
hyderabad Katılım Nisan 2011
333 Takip Edilen702 Takipçiler
Dr. Saadvik Raghuram y retweetledi

₹19,000 crore.
That is what Banks collected in last 3 years just for not maintaining ‘Minimum Account Balance.’
Not from the rich. Not from big borrowers.
From the poorest accounts in the system.
Their crime? They didn’t have enough money.
A farmer misses the minimum balance - Penalty.
A pensioner withdraws money for medicine - Penalty.
A daily wage worker falls short by a few hundred rupees - Penalty.
The poor keep money in banks for safety. Not to be quietly fined for being poor.
Financial inclusion should protect small savings, not punish small balances.
In Parliament today I proposed ending minimum balance penalties so the banking system stops charging people for their poverty.
English

PATINA STUDY⏩The addition of palbociclib to maintenance anti-HER2 and endocrine therapies led to a significant improvement in progression-free survival
@ChandrakanthMv
@OncoAlert @BreastCancerNow #MedTwitter
nejm.org/doi/full/10.10…


English
Dr. Saadvik Raghuram y retweetledi

🆕🗞️ A Vaccine💉for cancer🦀interception.
A preventative approach aiming to reduce cancer incidence by targeting precancers and early-stage cancers. For patients with Lynch syndrome. Out @NatureMedicine📰
Paradigm↩️intervene early✅
#Cancer @OncoAlert
nature.com/articles/s4159…

English

Prepregnancy GLP-1–Receptor Agonist Use and Pregnancy Outcomes @NEJMClinician @NEJM #MedTwitter clinician.nejm.org/prepregnancy-g…
English
Dr. Saadvik Raghuram y retweetledi

💉 GLP-1 works—but muscles decide the outcome.
🔬 A new meta-analysis (18 RCTs, ~3,800 participants) shows significant weight regain and worsening metabolic health after GLP-1 discontinuation
thelancet.com/journals/eclin…
English
Dr. Saadvik Raghuram y retweetledi

What’s the point in releasing such photos of the Indigo CEO sitting with folded hands, when the truth is that it is the government that has buckled and rolled back the FDTL norms and has been unsuccessful in taking stringent action for disruption in the skies?
The culprit isn’t the airline but those who turned a blind eye to the market capture& allowed things to fester till this point

English
Dr. Saadvik Raghuram y retweetledi

It’s time for #ASH25! Here is a📝 of 🔑studies from #CommunityOncologists perspective.
- #BRUINCLL313
- #WINDOW3
- #ALPINE
- #MajesTEC3
- #MRD in Myeloma
- #COBRA
- #AUGMENT101
- #GimemaALL2820
- #VAYHIT2
- #VERIFY
#mmsm #lymsm #leuksm #HemeTwitter @ASH_hematology

English

@OncBrothers @FDAOncology @OncoAlert @OncUpdates @YJanjigianMD @rutikamehtaMD @UGrewalMD @GIMedOnc @GIcancerDoc @rachnatshroff @NVijayvergiaMD @BijoyTelivala @RenoHemonc @dr_yakupergun @CathyEngMD Great news for gastric cancer patients. However 90% of the study population had PDL >/= 1. We don't know how the outcome will be for PDL1 Negative patients, as the numbers were very low in matterhorn.
English
Dr. Saadvik Raghuram y retweetledi

Durvalumab + FLOT—>✂️—>Durva now @FDAOncology ✅ for resectable GEJ/Gastric Ca based off #MATTERHORN study.
- ⭐️ Improved OS in all comers (HR: 0.78)
- Rate of✂️, # of FLOT, and AEs (Gr 3 & 4: 71%) similar in both arms.
#OncTwitter @OncoAlert @OncUpdates @YJanjigianMD 👏👏




ASCO@ASCO
5th Plenary #ASCO25: #MATTERHORN Ph III, Durvalumab + FLOT—>✂️—>Durva vs NeoAdj FLOT in resectable GEJ/Gastric Ca. - 2yr EFS 67% vs 59% (HR: 0.71). Improvement regardless of PDL1 - 2yr OS 76% vs 70%. mOS NR - Rate of✂️& number of FLOT similar in both arms - D-FLOT new SoC!
English
Dr. Saadvik Raghuram y retweetledi
Dr. Saadvik Raghuram y retweetledi

PeriOP Enfortumab + Pembro in cis-ineligible MIBC followed by postOP EV + Pembro now @US_FDA ✅ based off #KEYNOTE905 #EV303 study:
- EFS At 2yrs: 74.7% vs. 39.4%
- EFS HR: 0.40
- OS at 2yrs: 79.7% vs. 63.1 (HR: 0.50)
#OncTwitter #MedTwitter




English

@OncUpdates @myESMO @OncBrothers EV+Pembro is sure changing the treatment landscape of urothelial carcinomas
English

🚨 NEW FDA Approval ‼️
Pembrolizumab + Enfortumab Vedotin (EV) approved by FDA for neoadjuvant + adjuvant therapy in cisplatin-ineligible MIBC patients
⭐️FDA approval based off KEYNOTE-905/EV-303 presented @myESMO.
🔑 highlights 👇
#OncTwitter #MedTwitter @OncBrothers

OncUpdates@OncUpdates
#ESMO25 Highlights! #KEYNOTE905: PeriOP EV + Pembro in cis-ineligible MIBC followed by postOP EV + Pembro: 🎯EFS At 2yrs: 74.7% vs. 39.4% 📈EFS HR: 0.40 ✅OS at 2yrs: 79.7% vs. 63.1 (HR: 0.50) #MedTwitter #OncTwitter #OncTwitter #MedX
English

The FDA’s new “Plausible Mechanism Pathway” is a major step forward. It enables mutation-specific, bespoke therapies when trials aren’t feasible — a huge breakthrough for oncology & rare diseases.Faster access. Strong biological rationale.
nejm.org/doi/full/10.10…
English

@neerajaiims @ASCO @umangtalking @ggebraelmd @OncBrothers @ziremozay @shilpaonc @PGrivasMDPhD @TiansterZhang @apolo_andrea @VivekSubbiah @SWOG Full support and best wishes
English

Voting for the ASCO election is now open! I am honored to be running as one of the candidates for the @ASCO Nominating Committee seat. Visit asco.org/election to learn more about the candidates and place your vote! Thank you!!

English

At the end of life, what changes is not the care — but the goal of care.
When cure is no longer possible, comfort, clarity, and dignity become the treatment.
— Dr. Saadvik Raghuram
nejm.org/doi/full/10.10…
@NEJM @oncologician

English

In India, many breast cancers are detected late. We must change that.
My blog shares how Hyderabad women can lead the way.
drsaadvikraghuram.com/blog/october-b…
#BreastCancerAwareness #Hyderabad #WomenHealth
English

September is Childhood Cancer Awareness Month—a time to spotlight the signs every parent should know. From persistent fever to unexplained bruising, early detection changes outcomes. Learn the lifesaving SILUAN checklist and why timely action matters.
drsaadvikraghuram.com/blog/childhood…
#ChildhoodCancerAwareness #Cancer #Hyderabad
English




